Amgen presents new data that show blood decreases for adults treated with Krystexxa (pegloticase)
Amgen announced new data for Krystexxa (pegloticase) showing a decrease in blood pressure during treatment of adults living with chronic gout refractory to oral urate-lowering treatment; uncontrolled gout,… read more.
